|
Volumn 51, Issue 1, 2001, Pages 1-3
|
Is the α/β ratio for prostate cancer low?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
IODINE 125;
ISOTOPE;
ANIMAL CELL;
BRACHYTHERAPY;
CANCER CONTROL;
CANCER RADIOTHERAPY;
CLINICAL TRIAL;
COBALT THERAPY;
DOSE RESPONSE;
DRUG ACTIVITY;
DRUG HALF LIFE;
EDITORIAL;
EMBRYO;
HUMAN;
LUNG FIBROBLAST;
NONHUMAN;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROSTATE CARCINOMA;
RELATIVE BIOLOGIC EFFECTIVENESS;
SKIN FIBROBLAST;
SURVIVAL RATE;
TREATMENT PLANNING;
ALGORITHMS;
BRACHYTHERAPY;
DISEASE-FREE SURVIVAL;
DOSE FRACTIONATION;
DOSE-RESPONSE RELATIONSHIP, RADIATION;
HUMANS;
MALE;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
RELATIVE BIOLOGICAL EFFECTIVENESS;
TREATMENT FAILURE;
|
EID: 0035450297
PISSN: 03603016
EISSN: None
Source Type: Journal
DOI: 10.1016/S0360-3016(01)01650-9 Document Type: Editorial |
Times cited : (79)
|
References (14)
|